| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.001 |
1 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.00068 |
1 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.00064 |
1 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.00036 |
1 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00024 |
1 |
| mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.00015 |
1 |